Metabolomics for early-stage lung adenocarcinoma: diagnostic biomarker screening
ObjectiveThis study aimed to identify specific metabolic markers in the blood that can diagnose early-stage lung adenocarcinoma.MethodsAn untargeted metabolomics study was performed, and the participants were divided into four groups: early-stage lung adenocarcinoma group (E-LUAD; n = 21), healthy c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1535525/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|